epcoritamab
abbvie,genmab
['lymsm', 'epcoritamab']
#eha22 #lymsm thieblemont: epcoritamab subq assoc w ~50% crs, 15.3% gr2, 2.5% gr3. only 6.4% icans, all gr1-2. 53% discontinued due to pd. orr 63%, 39% cr. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)